In November 2023, C4T made the strategic decision to discontinue clinical development of CFT8634 based on clinical data from the Phase 1 trial. About C4 Therapeutics C4 Therapeutics is a ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Zyphra Technologies is announcing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback